5NG: [[(2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{R})-4-[[3-[2-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyldisulfanyl]ethylamino]-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] hydrogen phosphate
5NG is a Ligand Of Interest in 8VR6 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8VR6_5NG_A_201 | 60% | 56% | 0.124 | 0.91 | 0.62 | 0.92 | 1 | 7 | 0 | 0 | 100% | 1 |
| 8XJH_5NG_A_302 | 88% | 34% | 0.074 | 0.956 | 1.09 | 1.43 | 3 | 13 | 8 | 0 | 100% | 1 |
| 6C37_5NG_A_301 | 78% | 14% | 0.076 | 0.965 | 2.37 | 1.39 | 20 | 12 | 4 | 0 | 77% | 0.95 |
| 7OVV_5NG_B_301 | 77% | 3% | 0.109 | 0.954 | 4.02 | 2.09 | 47 | 32 | 7 | 0 | 100% | 1 |
| 9EMD_5NG_A_802 | 58% | 26% | 0.126 | 0.906 | 1.49 | 1.42 | 8 | 22 | 0 | 0 | 100% | 1 |
| 9EMT_5NG_A_401 | 54% | 24% | 0.142 | 0.907 | 1.6 | 1.45 | 11 | 21 | 1 | 0 | 100% | 0.5 |
